Sattva Sukun Lifecare Board of Directors
Get the latest insights into the leadership at Sattva Sukun Lifecare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Mit Tarunkumar Brahmbhatt | Managing Director |
| Mrs. Prajakta Anil Gangurde | Ind. Non-Executive Director |
| Mrs. Khushboo Vasudev | Ind. Non-Executive Director |
| Mr. Kishor Anil Kokate | Ind. Non-Executive Director |
Sattva Sukun Lifecare Share price
SATTVASUKU
0.79
0.01 (-1.25%)Last updated on 4 Nov, 2025 | 15:58 IST
BUYSELL
Today's High
0.81
Today's Low
0.79
52 Week Low
0.64
52 Week High
1.38
The current prices are delayed, login to your account for live prices
LoginSattva Sukun Lifecare FAQs
The board at Sattva Sukun Lifecare consists of experienced professionals, including Mr. Mit Tarunkumar Brahmbhatt , Mrs. Prajakta Anil Gangurde , and others, overseeing the company’s strategic and corporate governance.
Directors at Sattva Sukun Lifecare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Mit Tarunkumar Brahmbhatt is the current chairman at Sattva Sukun Lifecare.
Executive directors at Sattva Sukun Lifecare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sattva Sukun Lifecare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sattva Sukun Lifecare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.